57 related articles for article (PubMed ID: 3340891)
1. Very low glucose concentrations in hypocellular malignant pleural effusions.
Hernandez OG; Haponik EF; Wooden L; Summer WR
South Med J; 1988 Feb; 81(2):289. PubMed ID: 3340891
[No Abstract] [Full Text] [Related]
2. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
Liam CK; Lim KH; Wong CM
Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid pleural effusions: the case for a primary glucose transport defect.
Bankhurst AD; Rowe T
J Rheumatol; 1980; 7(1):110-1. PubMed ID: 7354461
[No Abstract] [Full Text] [Related]
4. The pathogenesis of low glucose concentrations in acidotic pleural fluid of tuberculous effusions.
Limthongkul S; Charoenlap P; Udompanich V; Nuchprayoon C; Songkhla YN
J Med Assoc Thai; 1988 Mar; 71(3):140-4. PubMed ID: 3133439
[No Abstract] [Full Text] [Related]
5. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
6. [Reduced pH, glucose and bicarbonate in malignant pleural effusions].
Lieberman D; Reshef A; Alroy G
Harefuah; 1984 Dec; 107(12):380-3. PubMed ID: 6532918
[No Abstract] [Full Text] [Related]
7. Pleural fluid glucose. Serial observation of its concentration following oral administration of glucose to patients with rheumatoid pleural effusions and malignant effusions.
Carr DT; McGuckin WF
Am Rev Respir Dis; 1968 Feb; 97(2):302-5. PubMed ID: 5637944
[No Abstract] [Full Text] [Related]
8. Differentiating tuberculous from malignant pleural effusions: a scoring model.
Porcel JM; Vives M
Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
[TBL] [Abstract][Full Text] [Related]
9. Laser high performance liquid chromatography determination of prostaglandins in pleural effusions.
Ikuta N; Sugiyama S; Takagi K; Hayakawa T; Ozawa T
Biochem Mol Biol Int; 1995 Jul; 36(3):521-7. PubMed ID: 7549950
[TBL] [Abstract][Full Text] [Related]
10. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
[TBL] [Abstract][Full Text] [Related]
11. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
Sears D; Hajdu SI
Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
Ni SS; Gao ZL
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
[TBL] [Abstract][Full Text] [Related]
13. Status of lipid peroxidation and antioxidant enzymes in malignant (bronchogenic carcinoma) and non-malignant pleural effusions.
Vanisree AJ; Shyamaladevi CS
Indian J Cancer; 1999; 36(2-4):127-34. PubMed ID: 10921216
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
15. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
16. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
17. Etiology and prognostic significance of massive pleural effusions.
Jiménez D; Díaz G; Gil D; Cicero A; Pérez-Rodríguez E; Sueiro A; Light RW
Respir Med; 2005 Sep; 99(9):1183-7. PubMed ID: 16085221
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion.
Elsammak M MY; Morsi TS; Khamis HI; Ragab MS; Zaki MA; Abdel-Hadi M; Hassan HA
Ann Clin Biochem; 2007 May; 44(Pt 3):264-72. PubMed ID: 17456294
[TBL] [Abstract][Full Text] [Related]
19. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
20. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
